These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9586268)

  • 21. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?
    Yucel S; Akkaya E; Guntekin E; Kukul E; Danisman A; Akman S; Baykara M
    Urology; 2005 Feb; 65(2):369-73. PubMed ID: 15708055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary evaluation of a new controlled-release oxybutynin in urinary incontinence.
    Radomski SB; Caley B; Reiz JL; Miceli PC; Harsanyi Z; Darke AC
    Curr Med Res Opin; 2004; 20(2):249-53. PubMed ID: 15006020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term prospective randomized study comparing two different regimens of oxybutynin as a treatment for detrusor overactivity.
    Salvatore S; Khullar V; Cardozo L; Milani R; Athanasiou S; Kelleher C
    Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):237-41. PubMed ID: 15808387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravesical oxybutynin: practicalities of clinical use.
    Guerrero K; Emery S; Owen L; Rowlands M
    J Obstet Gynaecol; 2006 Feb; 26(2):141-3. PubMed ID: 16483973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical effects of oxybutynin hydrochloride (Pollakis)--especially in the treatment of pollakisuria, urgency and urinary incontinence].
    Yamauchi K; Ohashi K; Osanai H; Inagaki N; Yamaguchi S; Hashimoto H; Yachiku S
    Hinyokika Kiyo; 1990 Dec; 36(12):1485-90. PubMed ID: 2075888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial.
    Malone-Lee J; Shaffu B; Anand C; Powell C
    J Urol; 2001 May; 165(5):1452-6. PubMed ID: 11342895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe Xerostomia Secondary to Anticholinergic Drug Therapy: Case Report.
    Brown RS; Rhodes BH; Siewe MS; Matthews TJ
    Dent Today; 2017 Feb; 36(2):136-8. PubMed ID: 29235767
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.
    Staskin DR; Dmochowski RR; Sand PK; Macdiarmid SA; Caramelli KE; Thomas H; Hoel G
    J Urol; 2009 Apr; 181(4):1764-72. PubMed ID: 19233423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A peripheric neuromodulation technique for curing detrusor overactivity: Stoller afferent neurostimulation.
    Karademir K; Baykal K; Sen B; Senkul T; Iseri C; Erden D
    Scand J Urol Nephrol; 2005; 39(3):230-3. PubMed ID: 16118096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of darifenacin and oxybutynin in patients with overactive bladder: assessment of ambulatory urodynamics and impact on salivary flow.
    Chapple CR; Abrams P
    Eur Urol; 2005 Jul; 48(1):102-9. PubMed ID: 15936869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose oxybutynin for the treatment of urge incontinence: good efficacy and few side effects.
    Bemelmans BL; Kiemeney LA; Debruyne FM
    Eur Urol; 2000 Jun; 37(6):709-13. PubMed ID: 10828672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A crossover randomized trial of transcutaneous electrical nerve stimulation and oxybutynin in patients with detrusor instability.
    Soomro NA; Khadra MH; Robson W; Neal DE
    J Urol; 2001 Jul; 166(1):146-9. PubMed ID: 11435843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of salivary stimulant pastilles to improve compliance in women taking oxybutynin hydrochloride for detrusor instability: a pilot study.
    Hooper P; Tincello DG; Richmond DH
    Br J Urol; 1997 Sep; 80(3):414-6. PubMed ID: 9313659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic value of moderate-dose oxybutynin in extensive hyperhidrosis].
    Maillard H; Fenot M; Bara C; Célérier P
    Ann Dermatol Venereol; 2011 Oct; 138(10):652-6. PubMed ID: 21978500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens.
    Di Stasi SM; Giannantoni A; Vespasiani G; Navarra P; Capelli G; Massoud R; Stephen RL
    J Urol; 2001 Feb; 165(2):491-8. PubMed ID: 11176403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of wetting is predictive of response to anticholinergic treatment in children with overactive bladder.
    Van Arendonk KJ; Austin JC; Boyt MA; Cooper CS
    Urology; 2006 May; 67(5):1049-53; discussion 1053-4. PubMed ID: 16698366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pharmacoeconomic evaluation of two new products for the treatment of overactive bladder.
    Arikian SR; Casciano J; Doyle JJ; Tarride JE; Casciano RN
    Manag Care Interface; 2000 Feb; 13(2):88-94. PubMed ID: 11067391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical efficacy of oxybutynin on sensory urgency as compared with that on motor urgency.
    Hashimoto K; Ohnishi N; Esa A; Sugiyama T; Park Y; Kurita T
    Urol Int; 1999; 62(1):12-6. PubMed ID: 10436424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuropsychiatric adverse effects attributed to use of oxybutynin].
    t'Veld BA; Kwee-Zuiderwijk WJ; van Puijenbroek EP; Stricker BH
    Ned Tijdschr Geneeskd; 1998 Mar; 142(11):590-2. PubMed ID: 9623118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: a subanalysis of data from the OPERA trial.
    Chu FM; Dmochowski RR; Lama DJ; Anderson RU; Sand PK
    Am J Obstet Gynecol; 2005 Jun; 192(6):1849-54; discussion 1854-5. PubMed ID: 15970828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.